Drug
AZD2066 clinical trials
Also written AZD2066.
- studies test it
- 10
- open now
- 0
- in phase 3
- 0
- first study started
- 2008
How studies write it
Studies that test it under each name
Development codes
- AZD2066
- 10
Studies by the year they started
10 studies that test it; most in 2008 (5)
| Year | Studies |
|---|---|
| 2008 | 5 |
| 2009 | 4 |
| 2010 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 7
- Phase 2
- 4
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 10 · Other 0
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses AZD2066 is read from its arms, and is right about nine times in ten.
Testing it · 10
- Study to Evaluate the Analgesic Efficacy of 28 Days' Oral Administration of AZD2066 Compared With Placebo in Patients With Painful Diabetic NeuropathyCompletedPhase 2AstraZenecaNCT00857623Written as AZD2066
- 6-week Study Treatment to Evaluate the Safety and Effectiveness of AZD2066 in Patients With Major Depressive DisorderTerminatedPhase 2AstraZenecaNCT01145755Written as AZD2066
- AZD2066 Neuropathic Pain - Mechanical HypersensitivityTerminatedPhase 2AstraZenecaNCT00939094Written as AZD2066
- Positron Emission Tomography (PET) Study With [11C]AZ12713580 to Determine Central mGluR5 Receptor Occupancy of AZD2066CompletedPhase 1AstraZenecaNCT00686504Written as AZD2066
- AZD 2066 Single Dose Formulation and Food Effect Study in Healthy VolunteersCompletedPhase 1AstraZenecaNCT00690404Written as AZD2066
- Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD2066 in Young and Elderly Healthy SubjectsCompletedPhase 1AstraZenecaNCT00684502Written as AZD2066
- 14473 - D9126C00001 Proof of Principle Study - Effect of AZD2066 on Transient Lower Esophageal Sphincter RelaxationsCompletedPhase 1/2AstraZenecaNCT00813306Written as AZD2066
- AZD2066 Cocktail StudyCompletedPhase 1AstraZenecaNCT00930306Written as AZD2066
- Study to Assess the Safety, Tolerability and Pharmacokinetics After Multiple Doses of AZD2066 in Japanese SubjectsCompletedPhase 1AstraZenecaNCT00766012Written as AZD2066
- Investigation of Rate + Extent of Excretion of Radioactivity in Urine +Faeces After Oral Administration of [14C]AZD2066CompletedPhase 1AstraZenecaNCT00829088Written as AZD2066